Objectives: To compare the trends in death rates and the causes of deaths before and after the introduction of highly active antiretroviral therapy. Methods: This is a retrospective study based on chart review of all HIV-related deaths between January 1997 and December 2005. Results: The HIV-specific death rate declined from 34.12 per 100 000 adult population during 1997-1999 to 17.21 per 100 000 adult population during 2003-2005 when highly active antiretroviral therapy was available. The proportion of all HIVrelated deaths among persons newly diagnosed with HIV during the terminal hospitalization decreased from 93% during 1997-1999 to 28% during 2003-2005. Opportunistic infection was at least one of the causes of death in nearly half of all cases. Conclusions: Although, the HIV-specific death rates have declined significantly since the introduction of highly active antiretroviral therapy, HIV infection continues to contribute to the premature deaths among adults, mainly because of the late presentation.
The introduction of highly active antiretroviral therapy (HAART) for the treatment of patients with HIV infection has led to a dramatic decline in both AIDS-defining illnesses and deaths. [1] [2] [3] [4] Although some retrospective reviews of mortality trends have been published, [5] [6] [7] [8] they are limited in duration or by the use of death certificates, which are frequently inaccurate 9 to ascertain the cause of death. It is reasonable to assume that the causes of death may be better determined using clinical and laboratory data in conjunction with death certificates. There are very few published data on the trends in the causes of death among persons with HIV infection in the Caribbean region 10 and none from English-speaking Caribbean regions.
We studied the trends in the HIV infectionrelated death rates, profiles of HIV-infected persons who died, and the causes of deaths in persons with HIV infection in Barbados during a 9-year period. We also compared these outcome measures for the period before the introduction of the provision for free HAART with those from after the introduction of the provision for free HAART in this country to ascertain the benefits of HAART. The determination of the most common terminal illnesses of HIV-infected persons may indicate where further health care research and intervention may be targeted to best serve the health care needs of persons living with HIV.
Methods
In Barbados, all HIV-infected persons receive their inpatient care at Queen Elizabeth Hospital, and ambulatory care is provided by a centralized HIV clinic that has operated from Ladymeade Reference Unit since 2002 and previously operated from the Respiratory Unit at Queen Elizabeth Hospital prior to 2002. Queen Elizabeth Hospital is the only public hospital providing more than 95% of all inpatient care to the entire population of this country. All deaths, including causes, are recorded in the death register at Queen Elizabeth Hospital. Clinical records of the HIV-infected persons have been maintained at Queen Elizabeth Hospital and at Ladymeade Reference Unit since the beginning of the HIV epidemic.
As the first step in the process of data collection, a list of all persons who died during the study period and who had HIV as one of the diagnoses at the time of death was compiled from the death register at Queen Elizabeth Hospital. This list was further supplemented and collated with records of deaths in HIV-infected persons at their own private house or in the special public hospice facility and not recorded in the death register at Queen Elizabeth Hospital maintained at the centralized HIV clinic for the follow-up, care, and treatment of HIV-infected persons in this country. This method maximized the possibility of covering all deaths in HIV-infected persons in Barbados.
In the second step, we recovered all records for all persons on the list of the HIV-infected persons who had died during the study period from the case dockets maintained at Queen Elizabeth Hospital and Ladymeade Reference Unit.
A review of the charts of all HIV-infected persons seen at Queen Elizabeth Hospital or Ladymeade Reference Unit and who died between January 1, 1997, and December 31, 2005, was undertaken by one of the authors, a physician experienced in HIV care; and the cause of death was critically evaluated. Standardized clinical information on dead patients was collected and collated from the death certificates and the inpatient (Queen Elizabeth Hospital) and the outpatient (Ladymeade Reference Unit) medical charts. Data collected included patient demographics, the date of diagnosis of the HIV infection, any previous follow-up for HIV infection, any previous and/or current antiretroviral medication used at the time of death, and the cause or causes of death.
Disease-specific death rate for HIV/AIDS was calculated by dividing the number of deaths in HIVinfected persons older than 16 years of age during a given time interval divided by the estimated midinterval population of adults older than 16 years and expressed as per 100 000 population. The proportion of all deaths attributable to HIV infection was calculated by dividing the number of deaths in HIVinfected persons older than 16 years of age during a given time interval divided by the total number of deaths from all causes in the defined age group of persons older than 16 years of age. The cause of death was categorized according to the underlying active condition, not the preterminal (ie, aspiration pneumonia) or terminal (ie, cardiopulmonary arrest) event. When the cause of death was not definitively documented, the probable cause was critically inferred, when possible, from the above clinical data using standard guidelines.
All data were stored in a predesigned Microsoft Access database (Microsoft Corp, Redmond, Wash). Descriptive and comparative statistical analyses were performed with standard parametric and nonparametric tests using SPSS statistical software, version 11.0 (SPSS Science Inc, Chicago, Ill). The 9-year period was further subdivided based on the availability of HAART into three 3-year subperiods as 1997-1999, 2000-2002, and 2003-2005 . For the purpose of comparison, 1997-1999, when no antiviral therapy was available, was taken as a baseline against which the period 2003-2005, when HAART was available for treatment, was compared. Few HIV-infected persons received antiretroviral therapy, mostly dual therapy, during the period 2000-2002. The χ 2 tests were used for analysis of proportional data, and P ≤ .05 was considered to be significant. Graphs were prepared with Microsoft Excel for Windows 95 version 7.0 (Microsoft Corp).
Results
In the 9-year study period from 1997 through 2005, there were 514 persons with HIV infection who died. The profile of these 514 persons is shown in Table 1 . The majority (53.7%) of these HIV-infected persons who died during 1997 through 2005 were in the 21-to 40-year age group, more than two thirds were males, and 36 (7.0%) self-reported to be men who had sex with men (all bisexuals). The median age at the time of death was 40 years (range, 20-75 years). Three hundred and seventy nine (73.7%) persons were diagnosed with the HIV infection for the first time during Figure 2 ). This decline was statistically significant (P < .0001). In 1997-1999, 1% of those diagnosed as HIV infected prior to their terminal admission and who died had any follow-up for their HIV infection, whereas in 2003-2005, 67% were on follow-up. Of the 101 persons who were known to be HIV infected prior to the terminal hospitalization and were on follow-up at Ladymeade Reference Unit or at Respiratory Unit, 36 (36%) were on HAART for a duration greater than 6 weeks, and an additional 29 (29%) were on HAART for a period less than 6 weeks at the time of their death.
Causes of death among the HIV-infected persons are shown in Table 2 . Overall, opportunistic infection was the most common (57.8%) cause of death, and it was at least one of the diagnoses at the time of death in 65.4% of all HIV-related deaths during the study period. Opportunistic infection was the most common (more than 40%) cause in HIV- 
Discussion
Barbados is one of the smaller countries in the English-speaking regions of the Caribbean, with an estimated 2001 population of 266 800 and a 2001 estimated per capita gross national product of US $14 010. The crude mortality rate for Barbados for 2001 was at 8.3 per 1000 population. 11 The adult prevalence rate of HIV in this country is 1.75%, with a male-to-female ratio of 2:1. 12 The government of Barbados views health care as a fundamental right of all Barbadians and aims to provide comprehensive health care to all its citizens through its elaborate, government-controlled health care facilities, free of cost at the point of delivery. The majority of the people with HIV infection who died during the study period were in the age group 21 to 40 years, which is in keeping with other published reports. However, we found that the proportion of the HIV-infected persons who died and were older than 40 years has increased during 2003-2005 as compared to 1997-1999, although this increase was not significant. Better follow-up care and treatment may have been responsible for longer life in this population. The proportion of all HIV deaths occurring in females was 30%, which is in keeping with the male-to-female ratio of 2:1 seen in the HIV-infected adult population in this country. However, despite the high male-to-female ratio in the HIV-infected population and among the persons with HIV infection who died in this country, only 7% reported to be men who had sex with men. This discrepancy may have resulted from the fact that there is a strong stigma attached to homosexuality and to the HIV infection, which is still considered by many in this society to be a disease of homosexuality, and very often, people do not report their homosexual behaviors. It is noteworthy that Barbados is one of the countries where homosexuality is a criminal offence! In fact, a recent attempt by the government to decriminalize homosexuality stirred strong debate both in the media and in the academic circle, which may have only fueled an already existing stigma toward this behavior.
With the availability of HAART since 2002 and the provision of care and treatment to all HIV-infected persons in Barbados free of all charges at the point of delivery; there has been a consistent decline in the HIV-specific death rate during the past 6 years (Figure 1) . The HIV-specific death rate dropped by 50% during 2003-2005, after the introduction of HAART, compared with the rate during 1997-1999 ( Figure 2 ). This finding is comparable with those of reports from several developing countries. [5] [6] [7] [8] However, late presentation with advanced immunodeficiency state continues to be a major problem, despite easy availability of treatment and care facility in this country since 2002. Nearly one third of HIV-infected persons who died during 2003-2005 was newly diagnosed (diagnosed during the terminal hospitalization), as shown in Figure 2 , and nearly half of those patients who were receiving HAART and who died commenced therapy within the month prior to their death. Late presentation has been a major cause of concern in this country, as has been reported previously, 13 and widespread stigma and discrimination may be an important issue underlying this problem. 14 A recently reported study from this country revealed that less than one third of the HIV-infected women had selfdisclosed their HIV status to significant others and that stigma and discrimination were the most common reasons cited for the nondisclosure of their HIV status. 15 Overall, AIDS-related conditions were at least 1 of the causes of death in more than four fifths of the HIV-infected persons who died during 1997 through 2005, both before and after the introduction of HAART in 2002. This finding is unlike the finding of an increasing proportion of AIDS-unrelated causes of death among these persons reported from developed countries in recent years [16] [17] [18] However, in these settings, HAART has been in use for more than 10 years. Reports from developing countries where HAART has been a more recent phenomenon, AIDS-related illnesses were the cause of death in the majority of the cases. [18] [19] The only published report on causes of deaths among HIV-infected persons from the Caribbean region is that from French-speaking Caribbean, where the opportunistic infection has been cited as the cause of death in a majority of the cases. 10 We found that opportunistic infections, especially toxoplasmosis and Pneumocystis carinii pneumonia, were the major AIDS-related events before deaths in more than two thirds of the HIV-infected persons dying in this country. The results of this review confirm that mortality from infections in general have decreased as a cause of death in HIV during the study period, mostly because of the decrease in numbers of deaths attributable to P carinii pneumonia. The proportion of all HIV deaths in which severe bacterial infection was at least one of the causes of death declined significantly from 28.9% in 1997-1999 to 3.8% in 2003-2005 ( Figure 3 ). Deaths attributed to opportunistic infections have also declined from 45.5% in 1997-1999 to 40.9% in 2003-2005, likely the result of both effective prophylaxis and improved diagnosis and treatment. However, this decline was not as dramatic as reported in some other reports. 20 Late presentation with advanced immunosuppression could be a possible explanation for the occurrence of opportunistic infections as one of the causes of death in this population. Of note, in a study among a highly HAART-experienced population in Dallas in the United States, it was reported that opportunistic infection continues to be a problem in a significant proportion of patients who were receiving HAART at the time of death. The authors concluded that P carinii pneumonia remained an important cause of death in the HAART era, possibly because more than 50% of HIV-infected patients who died were not receiving HAART. 8 There are several potential sources of bias in our retrospective study. Some of those dying after leaving the country may not have been included in this analysis. Data, although complete, were sometimes inadequate. For instance, definitive microbiological diagnoses and certain investigations, such as bronchoalveolar lavage to collect specimen for P carinii pneumonia tests, may not have been made in some infections, and therefore, such cases were often treated empirically. Case notes in some instances were inadequate or incomplete or missing all together. In addition, the multiplicity of disease processes in those with advanced HIV-related immunodeficiency may render the determination of the primary cause of death difficult.
Findings from this study underline the importance of early diagnosis as a critical element that would ensure success in curbing the HIV-related morbidity and mortality and would ensure full benefits from HAART, even in settings where HAART is becoming widely available to people at no direct cost. However, despite the above-mentioned limitations in the study design and frequency of late diagnosis, the results from this study provide sufficient evidence of significant benefits from HAART in this population and would help to refocus on the areas of concern that need to be addressed to maximize the potential benefits of the provision of excellent care and treatment facilities for the HIV-infected persons living in this country.
